Ikapharmindo Putramas Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp136 (market cap 268.02B, 36.96M 24h volume). The key difference: Ikapharmindo Putramas Tbk. and Trimegah Karya Pratama Tbk. are close in size by market cap, and Trimegah Karya Pratama Tbk. is more actively traded (36.96M versus 13.7K). Which is the better fit depends on your goals.
| IKPM | UVCR | |
|---|---|---|
Market Cap | 304.92B | 268.02B |
Volume | 13.7K | 36.96M |
Lot | 137 | 369.56K |
Turnover | 2.49M | 5.02B |
Average Price | 181.39 | 135.74 |
Value | 2.49M | 5.02B |
Indicative Equilibrium Price | — | 136 |
Indicative Equilibrium Volume | — | 2.08K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →